THRL vs. AGR, PHP, IHR, LABS, MXF, DLN, IWG, BYG, GPOR, and SRE
Should you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Primary Health Properties (PHP), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), Derwent London (DLN), IWG (IWG), Big Yellow Group (BYG), Great Portland Estates (GPOR), and Sirius Real Estate (SRE). These companies are all part of the "real estate" sector.
Target Healthcare REIT vs. Its Competitors
Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.
In the previous week, Assura and Assura both had 1 articles in the media. Assura's average media sentiment score of 0.51 beat Target Healthcare REIT's score of 0.47 indicating that Assura is being referred to more favorably in the media.
73.7% of Assura shares are owned by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are owned by institutional investors. 8.4% of Assura shares are owned by company insiders. Comparatively, 0.1% of Target Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Assura pays an annual dividend of GBX 3 per share and has a dividend yield of 6.0%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 5.9%. Assura pays out -286.8% of its earnings in the form of a dividend. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Assura is clearly the better dividend stock, given its higher yield and lower payout ratio.
Target Healthcare REIT has lower revenue, but higher earnings than Assura. Assura is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.
Assura has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.
Assura currently has a consensus target price of GBX 51, indicating a potential upside of 2.00%. Given Assura's stronger consensus rating and higher possible upside, research analysts plainly believe Assura is more favorable than Target Healthcare REIT.
Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.09%. Target Healthcare REIT's return on equity of 10.78% beat Assura's return on equity.
Summary
Assura beats Target Healthcare REIT on 9 of the 17 factors compared between the two stocks.
Get Target Healthcare REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Target Healthcare REIT Competitors List
Related Companies and Tools
This page (LON:THRL) was last updated on 7/5/2025 by MarketBeat.com Staff
Free THRL Stock Alerts